Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118344244A enables visible light catalyzed deuteration using D2O. Offers cost reduction and scalable supply for high-purity pharmaceutical intermediates.
Patent CN100564365C details a streamlined 2-step synthesis for Anastrozole, offering superior purity and cost efficiency for pharmaceutical manufacturing.
Patent CN112574108A reveals a metal-free iodine-catalyzed route for benzo[b]azepines. Offers high yield, mild conditions, and cost-effective manufacturing for pharmaceutical intermediates.
Novel one-pot synthesis of spiroisoxazolines from dihydrochalcones. High yield, mild conditions, cost-effective pharmaceutical intermediate manufacturing.
Novel asymmetric dearomatization method for chiral benzofurans with high enantioselectivity. Offers cost-effective routes for pharmaceutical intermediates.
Patent CN113620859A discloses a transition-metal-free route for indeno-indole ketones. This method reduces purification costs and ensures high purity for API intermediates.
Novel ruthenium catalyst enables low-loading synthesis of quinoline derivatives reducing costs and improving supply chain reliability for pharmaceutical intermediates.
Patent CN115010716B reveals mild cyclization for polysubstituted pyridines. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable supply.
Patent CN106242935A reveals a green water-oil two-phase synthesis for triaryl chiral compounds. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN104447739B details deuterated Palbociclib derivatives enhancing bioavailability. We offer scalable synthesis for reliable API intermediate supply chains.
Novel phosphite ester patent CN120504699A enables mild asymmetric hydrogenation. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN105017334A reveals single Λ-configuration cobalt catalysts. Enhances asymmetric synthesis efficiency and supply chain stability for pharmaceutical intermediates.
Patent CN108947880B reveals a metal-free visible light method for thiocarbamates. Eliminate toxic phosgene, reduce costs, and ensure supply continuity with our advanced green chemistry solutions.
Patent CN101659668A discloses novel routes for Irinotecan and Topotecan intermediates, offering significant cost reduction in API manufacturing through improved oxidation and alkylation strategies.
Patent CN102010376B details an aqueous phase synthesis for quinoxalines using biodegradable ionic liquids, offering high yields and eco-friendly processing for pharmaceutical intermediates.
Patent CN112574225A details a room-temperature gold-catalyzed synthesis of tetrahydrofuran dihydroquinolines, offering high yields and simplified processing for pharmaceutical supply chains.
Patent CN103012319B reveals high-yield DEPBT method for repaglinide intermediates, ensuring supply chain stability and cost reduction.
Novel 3-step route using 2-amino-5-methylbenzoic acid ensures high purity >99% and cost reduction in obesity drug manufacturing.
Novel high-yield synthesis of LND1067 linker for ADCs. Optimized route avoids low-yield intermediates, ensuring cost reduction and supply reliability for pharmaceutical manufacturing.
Patent CN103450073A details a novel rigid chiral catalyst synthesis offering superior stereoselectivity and cost-effective manufacturing for complex pharmaceutical intermediates.